Exhibit
10.3

     

    CORPORATE COMMUNICATIONS
CONSULTING AGREEMENT

     

    SECTION
1.0 SERVICE TO BE PROVIDED BY MICHAEL SOUTHWORTH OR ASSIGNEE.

     

    By virtue
of this Engagement subject to both parties being in compliance with the Terms
and Conditions contained herein, Michael Southworth, an individual residing at
2638 North Chestnut Circle, Mesa, Arizona 85213 (the “Consultant”) shall
undertake to provide to China Yongxin Pharmaceuticals, Inc., a Delaware
corporation having an office at 927 Canada Court, City of Industry, California
91748 (the “Company”);

     

    CORPORATE
COMMUNICATION SERVICES

     

    Company
hereby authorizes, appoints and engages Consultant, and Consultant agrees to be
available to consult with Company’s officers and directors for a period of three
months on projects agreed to in writing by the parties. Company may request
Consultant to work on projects in the following areas (“Consulting
Services”):

     

    
      	
              1.1

            	
              Consultant will provide
      consulting direction in regards to introduction and
      contacting, correspondence, and communication with new and existing
      investors.

            


    

    


    
      	
              1.2

            	
              Consultant shall undertake to
      provide further ongoing Corporate Communication Services by arranging
      and executing group presentations, conference calls to qualified Exchange
      Members, Shareholders, Portfolio Managers, Institutional Fund Managers,
      Pension Fund Managers, etc.

            


    

    


    
      	
              1.3

            	
              Consultant shall undertake to
      provide consulting on materials, which highlight Company’s
      history, business, status, prospects, strategies, etc., for
      distribution to qualified Capital Market Participants (includes current
      Shareholder, Industry Sector Investors, Brokers and Analysts, and the
      appropriate Financial Media). The materials will be prepared from
      information provided by the
Client.

            


    

    


    
      	
              1.4

            	
              Consultant shall undertake to
      assist and provide consulting with the goal of taking Company to
      larger stock exchange status when
  ready.

            


    

    


    FURTHER:

     

    All
Services Shall Be On A best Efforts Basis.

     

    Consultant
agrees that he will at all times, faithfully and to the best of his experience,
ability and talents, perform all the duties and responsibilities outlined
herein, pursuant to the terms of this Agreement. Consultant does not guarantee
that his efforts will have any impact on Company’s business or that any
subsequent financial improvement or investments will result from Consultants
efforts. Company understands and acknowledges that the success or failure of
Consultant’s efforts will be predicated on Company’s business operations and
results.

     

     All information materials to be
publicly circulated by Consultant on behalf of Company shall be put before
management for prior approval.

     

    SECTION
2.0 FEES & DISBURSEMENTS

     

    In
consideration for service Michael Southworth and associates will provide,
Company agrees to make payable to Michael Southworth or assignee the following
fees and disbursements:

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    2.1
Compensation for services shall be paid as follows;

     

    
      	
               
      

            	
              a. 

            	
              Michael Southworth or assignee
      shall be issued One Million (1,000,000) shares in China Yongxin
      Pharmaceuticals, Inc.

            


    

    
      	
               
      

            	
              b.

            	
              Michael
      Southworth shall be paid Thirty Five Thousand Dollars ($35,000) in cash as
      an initial sign on bonus. This payment is due and payable once the
      contract is in effect (See “consideration trigger” below, which fee
      is non-refundable.

            


    

     

    The
obligations of the Company to issue One Million (1,000,000) shares of the above
mentioned stock and to pay the full cash consideration, will accrue and arise
only in the event the Company is successful in raising $250,000 minimum in the
anticipated upcoming private placement (the “consideration Trigger”). In the
event the consideration trigger is not reached by the date which is three (3)
months from the date of this Agreement, then the Company may terminate this
Agreement in accordance with Section 4.0 with no obligations
whatsoever.

    


    2.2
OPTIONS

    


    No
options shall be given to Consultant.

    


    2.3
DISBURSEMENTS

    


    Consultant
shall pay for its own expenses.

    


    2.4
INTEREST

    


    None
whatsoever.

    


    2.5
CURRENCY

    


    All funds
are to be paid in US currency.

     


    SECTION
3.0 OBLIGATIONS OF COMPANY

    


    By virtue
of this Engagement and subject to both parties being in compliance with the
Terms and Conditions contained herein, Company shall undertake to provide
Consultant:

    


    3.1
INFORMATION

    


    Upon
commencement of the Engagement, Company shall provide Consultant a list of
Corporate Information. Said list is to be provided, and is required, to
Consultant to perform the duties as described herein. Company acknowledges that
not all information provided to Consultant will be utilized; however inclusion
of such information is essential for Consultant to perform its duties per the
Engagement.

    


    Consultant
acknowledges that some information received to be of a highly confidential
nature, and warrants that said confidentiality shall be maintained at Company’s
request, provided such requests does not hinder Consultant’s ability to perform
its duties and/or cause Consultant to be in contravention of any applicable
legislation or restrictions relating to disclosure of material
facts.

    


    SECTION
4.0 TERMINATIONS

    


    4.1 
         Company shall retain the right to terminate
the Engagement at any time upon appropriate notice being given to Consultant.
Appropriate notice shall be deemed to be 30 days prior to the intended
termination date. Consultant shall retain the right to terminate the Engagement
at anytime in the event that he cannot provide services in accordance with Section 1 of this
Engagement.

    


    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    4.2 
         Upon termination of this Engagement by either
party, subject to the Consideration Trigger set forth in Section 2.0 above,
Company shall remain responsible for any and all outstanding fees or
disbursements payable to Consultant under this Agreement, as per effective
date of termination.

    


    SECTION
5.0 CONFIDENTIALITY

    


    5.1 
         Consultant acknowledges that any and all
knowledge or information concerning Company and its affairs obtained by
Consultant, it’s principals, employees and/or contractors in the course of his
engagement hereunder will be deemed “confidential”, Consultant will not impart
any such knowledge to any whosoever during or after the term of
hereof.

    


    As used
herein, “confidential” knowledge or information means: (a) all information
regarding Company, which is not generally available to the public; and (b) all
information regarding Company, which was received by Consultant from a source
with confidentiality obligations to Company.

    


    Consultant
shall, upon the termination of his Engagement by Company for any reason
whatsoever, immediately surrender and turn over to Company all “confidential”
material including, but not limited to, books, forms, records, papers/writings
and all other property relating or belonging to Company.

    


    This
section shall survive termination of this Agreement.

    


    SECTION
6.0 INDEMNITIES

    


    6.1 
         Company does hereby agree to indemnify
Consultant against any and all claims brought against Consultant by third
parties, said claims arising as a result of this Agreement. In addition, Company
agrees that any claims it may assert against Consultant will be limited to the
strict performance of this Agreement. Any claims that may arise will exclude
monetary damages.

    


     SECTION 7.0 REPRESENTATIONS OF
COMPANY, INC. AND CONSULTANT

    


    Consultant
hereby represents and warrants as follows:

    


    7.1 POWER
AND AUTHORITY

    


    Consultant
has the power to execute and deliver this Agreement, has taken all action
required by law to authorize such execution and delivery, and this Agreement is
a valid and binding obligation of Consultant in accordance with its
terms.

    


    7.2
INSIDE INFORMATION, SECURITES LAWS VIOLATIONS

    


    Consultant
in the course of the performance of its duties, may become aware of information
which may considered “inside information” within the meaning of the Federal
Securities Laws, Rules and Regulations. Consultant acknowledges that the use of
such information to purchase or sell securities of Company, or its affiliates,
or to transmit such information to any other party with a view to buy, sell, or
otherwise deal in Company securities, is prohibited by law and would constitute
a breach of this Agreement.

    


    Company
hereby represents and warrants as follows:

    


    This
Agreement has been duly authorized, and executed by Company and is a binding
obligation of Company, enforceable in accordance with its terms, except as
rights to indemnity hereunder may be limited by applicable federal or state
securities laws, except in each case as such enforceability may be limited by
bankruptcy, insolvency, reorganization or similar laws affecting creditor’s
rights generally.

    


    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    SECTION
8.0 ALTERATION OF THIS AGREEMENT

    


    8.1 
        Any notice, request, demand, or other communication
given pursuant to the terms of this Agreement shall be deemed given upon
delivery, and may only be delivered or sent via hand delivery, facsimile, or by
overnight courier, correctly addressed to the addresses of the parties indicated
below or at such other address as such party shall in writing have advised the
other party.

     

    Michael
Southworth

    2638 N.
Chestnut Circle

    Mesa,
Arizona 85213

    


    China
Yongxin Pharmaceuticals, Inc.

    927
Canada Court

    City of
Industry, California 91748

    


    SECTION
10.0 INDEPENDENT CONTRACTOR

    


    Both
Company and the Consultant agree that the Consultant will act as an independent
contractor in the performance of his duties under this Agreement. Nothing
contained in this Agreement shall be construed to imply that Consultant, or any
employee, agent or other authorized representative of Consultant, is a partner,
joint venture, agent, officer or employee of Company. Neither party hereto shall
have any authority to bind the other in any respect vis a vis any third party,
it being intended that each shall remain an independent contractor and
responsible only for its actions.

    


    SECTION
11.0 CHOICE OF LAW AND VENUE

    


    This
Agreement and the rights of the parties hereunder shall be governed by and
construed in accordance with the laws of the State of Utah including all matters
of construction, validity, performance, and enforcement and without giving
effect to the principles of conflict of laws, any action brought by any party
hereto shall be brought within the County of Salt Lake, State of
Utah.

    


    SECTION
12.0 SEVERABILITY

    


    If any
provision of this Agreement is unenforceable, invalid, or violates applicable
law, such provision, or unenforceable portion of such provision, shall be deemed
stricken and shall not affect the enforceability of any other provisions of this
Agreement.

     

    SECTION
13.0 MODIFICATION

    


    No
change, modification, addition, or amendment to this Agreement shall be valid
unless in writing and signed by all parties hereto.

    


    SECTION
14.0 SIGNATURES

    


    Agreement
may be executed in one or more counterparts, each of which shall be deemed an
original, but all of which shall together constitute one and the same
instrument. Signature upon this document shall signify acceptance of the terms
and conditions of the Engagement contained herein.

     

    
      
         


      

      
         


        
          

        

      

      
         


      

    


    IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be duly executed as of this date,
July 2nd, 2009.

     

    
      	
              “COMPANY”

            	
              “CONSULTANT”

            
	
              [sig1]

            	 
      
	
              China
      Yongxin Pharmaceuticals, Inc.,

            	 
      
	 
      	 
      
	
              a
      Delaware corporation

            	 
      


    

     

    
      
        
          
            	 
      	 
      	
                    

                  
	 
      	 
      	 
      	 
      
	
                    By:

                  	 
      	 
      	
                    Michael
      Southworth, an individual

                  
	 
      	 
      	 
      	 
      
	
                    Its: